Mohammad Zamani

Dados Biográficos

ID7804582
NOMEMohammad Zamani
PRENOMESMohammad
SOBRENOMEZamani
ASSINATURAZAMANI M
AFILIAÇÕESShariati Hospital
ORCID0000-0003-1916-3873
VERIFICADOSim
TOTAL DE OBRAS23
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR23
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2018
ANO MAIS RECENTE DE PUBLICAÇÃO2023
ÍNDICE H0

  • Fragments of a Revolution

    Open AccessYassaman Khajehi, Mohammad Amin Zamani et al.ARTICLETDR/The Drama Review2023

    With the Iranian protest movement “Woman, Life, Freedom,” public spaces have become scenes of collective performance. As women openly defy the authoritarian and religious powers, theatre artists are faced with a question: What role can we imagine for theatre when citizens themselves perform their struggle to reclaim the public space and sphere of power

  • Sars-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With Covid-19 Patient's Referral in Tehran, Iran

    Open AccessMaryam Darvishian, Maryam Sharafkhah et al.ARTICLEFrontiers in Public Health2022

    Estimating the prevalence of SARS-CoV-2 antibody seropositivity among health care workers (HCWs) is crucial. In this study, the seroprevalence of anti-SARS-CoV-2 antibodies among HCWs of five hospitals of Tehran, Iran with high COVID-19 patient's referrals from April to June, 2020, was assessed. In this cross-sectional study, HCWs from three public and two private hospitals, selected randomly as a pilot, were included. Participants were asked que…

  • Seroprevalence of Sars-CoV-2 antibody among urban Iranian population

    Open AccessMohammad Zamani, Hossein Poustchi et al.ARTICLEBMC Public Health2022

    Nearly one in three individuals were exposed to SARS-CoV-2 in the studied cities by March 2021. The seroprevalence increased about two-fold between April, 2020, and March, 2021

  • Anemia prevalence, severity, types, and correlates among adult women and men in a multiethnic Iranian population

    Open AccessElham Akbarpour, Yousef Paridar et al.ARTICLEBMC Public Health2022

    Taken together, the anemia prevalence in this study population was of mild public health significance. The major suspected causes might be iron deficiency and chronic disease anemias. Comparably higher rates of anemia were observed amongst women, individuals aged 35-49 years, underweights, unemployed or retired subjects, and urban residents

  • Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health

    Open AccessKatherine R Paulson, Katherine Paulson et al.ARTICLEThe Lancet2021

    BACKGROUND: Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, a…

  • Hearing loss prevalence and years lived with disability, 1990–2019

    Open AccessLydia M Haile, Kaloyan Kamenov et al.ARTICLEThe Lancet2021

    BACKGROUND: Hearing loss affects access to spoken language, which can affect cognition and development, and can negatively affect social wellbeing. We present updated estimates from the Global Burden of Disease (GBD) study on the prevalence of hearing loss in 2019, as well as the condition's associated disability. METHODS: We did systematic reviews of population-representative surveys on hearing loss prevalence from 1990 to 2019. We fitted nested…

  • Global age-sex-specific fertility, mortality, healthy life expectancy (Hale), and population estimates in 204 countries and territories, 1950–2019

    Open AccessHaidong Wang, Kaja Abbas et al.ARTICLEThe Lancet2020

    BACKGROUND: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected sub…

  • Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017

    Open AccessJoan B Soriano, Parkes J Kendrick et al.ARTICLEThe Lancet Respiratory Medicine2020

    BACKGROUND: Previous attempts to characterise the burden of chronic respiratory diseases have focused only on specific disease conditions, such as chronic obstructive pulmonary disease (COPD) or asthma. In this study, we aimed to characterise the burden of chronic respiratory diseases globally, providing a comprehensive and up-to-date analysis on geographical and time trends from 1990 to 2017. METHODS: Using data from the Global Burden of Disease…

  • Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019

    Open AccessR Lozano, Nancy Fullman et al.ARTICLEThe Lancet2020

    BACKGROUND: Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system le…

  • Global burden of 87 risk factors in 204 countries and territories, 1990–2019

    Open AccessChristopher J L Murray, Aleksandr Y Aravkin et al.ARTICLEThe Lancet2020

    BACKGROUND: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attribu…

  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019

    Open AccessTheo Vos, Stephen S Lim et al.ARTICLEThe Lancet2020

    BACKGROUND: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive…

  • Suicidal Behavior in Iran

    Open AccessMohammad Zamani, Vahid ZamaniARTICLEJournal of Religion and Health2020

  • Global, regional, and national burden of neurological disorders, 1990–2016

    Open AccessValery L Feigin, Emma Nichols et al.ARTICLEThe Lancet Neurology2019

    BACKGROUND: Neurological disorders are increasingly recognised as major causes of death and disability worldwide. The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 is to provide the most comprehensive and up-to-date estimates of the global, regional, and national burden from neurological disorders. METHODS: We estimated prevalence, incidence, deaths, and disability-adjusted life-years (DALYs;…

  • Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

    Open AccessChristina Fitzmaurice, Global Burden of Disease Cancer Collaboration et al.ARTICLEJAMA Oncology2019

    Importance Cancer and other noncommunicable diseases (NCDs) are now widely recognized as a threat to global development. The latest United Nations high-level meeting on NCDs reaffirmed this observation and also highlighted the slow progress in meeting the 2011 Political Declaration on the Prevention and Control of Noncommunicable Diseases and the third Sustainable Development Goal. Lack of situational analyses, priority setting, and budgeting hav…

  • Global, regional, and national burden of stroke, 1990–2016

    Open AccessCatherine Owens Johnson, Minh Nguyen et al.ARTICLEThe Lancet Neurology2019

    BACKGROUND: Stroke is a leading cause of mortality and disability worldwide and the economic costs of treatment and post-stroke care are substantial. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic, comparable method of quantifying health loss by disease, age, sex, year, and location to provide information to health systems and policy makers on more than 300 causes of disease and injury, including strok…

  • Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017

    Open AccessDaniel Dicker, Grant Nguyen et al.ARTICLEThe Lancet2018

    BACKGROUND: Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent wit…

  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017

    Open AccessGregory A Roth, D Abate et al.ARTICLEThe Lancet2018

    BACKGROUND: Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD …

  • Alcohol use and burden for 195 countries and territories, 1990–2016

    Open AccessMax Griswold, Max G Griswold et al.ARTICLEThe Lancet2018

    BACKGROUND: Alcohol use is a leading risk factor for death and disability, but its overall association with health remains complex given the possible protective effects of moderate alcohol consumption on some conditions. With our comprehensive approach to health accounting within the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we generated improved estimates of alcohol use and alcohol-attributable deaths and disability-adjus…

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017

    Open AccessJeffrey D Stanaway, Ashkan Afshin et al.ARTICLEThe Lancet2018

    BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk–outcome pairs, and new data on risk exposure levels and risk–outcome associatio…

  • Global, regional, and national disability-adjusted life-years (Dalys) for 359 diseases and injuries and healthy life expectancy (Hale) for 195 countries and territories, 1990–2017

    Open AccessHmwe Hmwe Kyu, D Abate et al.ARTICLEThe Lancet2018

    BACKGROUND: How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure o…

  • Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations

    Open AccessNancy Fullman, Jamal A Yearwood et al.ARTICLEThe Lancet2018

    BACKGROUND: A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthc…

  • Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories

    Open AccessR Lozano, Nancy Fullman et al.ARTICLEThe Lancet2018

    BACKGROUND: Efforts to establish the 2015 baseline and monitor early implementation of the UN Sustainable Development Goals (SDGs) highlight both great potential for and threats to improving health by 2030. To fully deliver on the SDG aim of "leaving no one behind", it is increasingly important to examine the health-related SDGs beyond national-level estimates. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2…

  • Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017

    Open AccessL James, Spencer L James et al.ARTICLEThe Lancet2018

    BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories from 1990 to 2017. Previous GBD studies have shown how the decline of mortality rates from 1990 to 2016 has led to an increase in life expectancy, an ageing global population, and an expansion of the non-fatal…